Changes in Lab and Ultrasonography After Endoscopic Varisceal Treatment
Laoboratory and Ultrasonographic Changes After Endoscopic Varisceal Treatment
1 other identifier
observational
100
1 country
1
Brief Summary
laboratory and ultrasongraphicc changes after endoscopical varices treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2017
CompletedFirst Posted
Study publicly available on registry
September 1, 2017
CompletedStudy Start
First participant enrolled
November 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedOctober 9, 2018
October 1, 2018
1 year
August 27, 2017
October 7, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Changes in liver function tests
Liver function tests (ALT, AST, bilirubin,Albumin,Cbc,Prothrombin time,INR ) level (expected to be lower after endoscopic varisceal treatment (ex
6 months
Ultrasonographic changes
{ portal vein diameter , portal vein velocity and flow direction, volume flow in portal vein , congetive index, spleen size.(expected to be chnged after endoscopic varisceal treatment
6 months
Study Arms (1)
cirrhotic patients with esophagel varisces
Endoscopic band ligation or injection scelerotheraby will be done for all patients
Interventions
Liver function tests will be assessed after endoscopic varisceal treatment for 6 monthes
portal vein diameter , portal vein velocity and flow direction, volume flow in portal vein , congetive index, spleen size.will be assessed after endoscopic varisceal treatment by using biannual ultrasonography for 6 monthes
Eligibility Criteria
patients with liver cirrhosis and portal hyprtension with esophagel varisces
You may qualify if:
- patients with liver cirrhosis and portal hyprtension with esophagel varisces
You may not qualify if:
- \. Patients with heart failure or renal failure 2. patients with COPD 3. Patients with hepato cellular carcinoma and portal vein thrombosis 4. Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University
Asyut, 171516, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
August 27, 2017
First Posted
September 1, 2017
Study Start
November 1, 2018
Primary Completion
November 1, 2019
Study Completion
November 1, 2019
Last Updated
October 9, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share